Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data From a Non-Interventional, Multicenter Study in Germany

Diabetes Therapy - United States
doi 10.1007/s13300-018-0513-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data From a Prospective Study and Predictive Factors for Visual Outcome

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment

Ophthalmology
Ophthalmology
2012English

Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment: 5-Year Randomized Trial Results

Ophthalmology
Ophthalmology
2015English

Comparative Study of Intravitreal Ranibizumab With and Without Nepafenac Eye Drops for Center Involving Diabetic Macular Edema

Journal of Medical Science And clinical Research
2015English

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

Ophthalmology
Ophthalmology
2016English

Dexamethasone Implant in Diabetic Macular Edema in Real-Life Situations

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2016English

Pss34 - Cost-Effectiveness of Intravitreal Aflibercept Versus Ranibizumab in the Treatment of Diabetic Macular Edema in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema

JAMA Ophthalmology
Ophthalmology
2018English

Intravitreal Corticosteroids in the Management of Diabetic Macular Edema

Current Ophthalmology Reports
Ophthalmology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy